DexCom revenue and financials

DXCM · NASDAQ · USD

$83.39−4.04%−$3.51

Close · October 6, 2026

In the fiscal year ended December 2025, DexCom reported revenue of $4.66B (+15.60% year over year). Net income was $836.3M, a net margin of 17.9%.

Annual revenue · 2025: $4.66B
  1. $573.3M2016
  2. $718.5M2017
  3. $1.03B2018
  4. $1.48B2019
  5. $1.93B2020
  6. $2.45B2021
  7. $2.91B2022
  8. $3.62B2023
  9. $4.03B2024
  10. $4.66B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+15.60%
2025 vs 2024
Net income growth
+45.14%
2025 vs 2024
Net margin
17.9%
2024: 14.3%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue1,3081,1921,2601,2091,1571,0361,1149941,0049211,035975
Cost of revenue478442467478468447458400378359378352
Gross profit830750793731689589656594627562657623
Selling, general and administrative359350322331328310327306333319304286
Research and development153145148158148145140135136142136131
Operating income318255323243213134189152158101217206
EBIT318255323243213134189152158101217206
EBITDA387322388306276194247207210154269254
Interest expense3.03.14.24.74.74.74.94.74.84.64.94.9
Pre-tax income318270341352241154211177188133246240
Income tax68.470.073.468.561.348.959.642.844.3-13.9-10.1120
Net income249200267284180105152135144146256121
Net income to common shareholders249200267284180105152135144146256121
Basic EPS0.650.520.690.730.460.270.390.340.360.380.670.31
Diluted EPS0.640.510.680.700.450.270.380.340.350.360.620.29
Average shares (basic)382385387391392391391394399390384387
Average shares (diluted)390394399407408408407410417417416427